Dyslipidaemia in rural Australia : the evidence treatment gaps

McNamara, K., Janus, E., Tideman, P., Kilkkinen, A., Dunbar, J., Bunker, S., Philpot, B., Tirimacco, R., Heistaro, S. and Laatikainen, T. 2008, Dyslipidaemia in rural Australia : the evidence treatment gaps, in GP & PHC 2008 : Proceedings of the General Practice and Primary Health Care Research Conference : Health for All?, Primary Health Care Research Information Service, [Hobart, Tas.].

Attached Files
Name Description MIMEType Size Downloads

Title Dyslipidaemia in rural Australia : the evidence treatment gaps
Author(s) McNamara, K.
Janus, E.
Tideman, P.
Kilkkinen, A.
Dunbar, J.
Bunker, S.
Philpot, B.
Tirimacco, R.
Heistaro, S.
Laatikainen, T.
Conference name General Practice and Primary Health Care Research Conference (2008 : Hobart, Tas.)
Conference location Hobart, Tas.
Conference dates 4-6 June 2008
Title of proceedings GP & PHC 2008 : Proceedings of the General Practice and Primary Health Care Research Conference : Health for All?
Publication date 2008
Publisher Primary Health Care Research Information Service
Place of publication [Hobart, Tas.]
Summary Aims & rationale/Objectives : Hypercholesterolaemia accounts for 11.6% of total deaths and 6.2% of the disability burden for the Australian population.1 This paper reports population lipid profiles for three rural Australian populations, and assesses evidence-treatment gaps against the most recent (2005-2007) Australian guidelines.

Methods :
Three population surveys were undertaken in the Greater Green Triangle. 3,320 adults aged 25-74 yrs were randomly selected using age/gender stratified electoral roll samples and of these 1563 subjects participated in the survey. Anthropometric, clinical and self-administered questionnaire data relating to chronic disease risk were collected in accordance with the WHO MONICA protocol.2 A detailed investigation of dyslipidaemia was included.

Principal findings : All required data was available for 1255 participants. Age-standardised mean total cholesterol (TC), triglycerides, LDL cholesterol and HDL cholesterol concentrations were 5.36 mmol/l, 1.42 mmol/l, 3.23 mmol/l and 1.48 mmol/l, respectively. Amongst those taking lipid-lowering medication, just 11% categorised as secondary prevention/diabetes, and 39% as primary prevention, achieved all lipid targets. In the 20% of untreated participants at high risk of a primary cardiovascular event, 26% were aware of their hypercholesterolaemia and just 2% achieved all lipid targets (2.8% achieved TC?5.5 mmol, 8.5% achieved LDL<3.5 mmol/l). 11.2% of the overall population used lipid-lowering medication (95% was statin monotherapy).

Implications : Most adults do not achieve their target lipid profile. This paper identifies the subpopulations and lipid components which need to be targeted for future interventions. It also identifies substantial evidence-treatment gaps which should be addressed to help improve lipid profiles at a population level.
Language eng
Field of Research 111717 Primary Health Care
Socio Economic Objective 920506 Rural Health
HERDC Research category E3 Extract of paper
Copyright notice ©2008, Primary Health Care Research Information Service
Persistent URL http://hdl.handle.net/10536/DRO/DU:30019226

Document type: Conference Paper
Collection: School of Medicine
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Access Statistics: 319 Abstract Views, 3 File Downloads  -  Detailed Statistics
Created: Fri, 11 Sep 2009, 10:40:29 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.